{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:06:19Z","timestamp":1774253179662,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972475"],"award-info":[{"award-number":["81972475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103557"],"award-info":[{"award-number":["82103557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH245"],"award-info":[{"award-number":["ZR2020QH245"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancerforeningen i Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.biopha.2022.112796","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:56:19Z","timestamp":1646916979000},"page":"112796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma"],"prefix":"10.1016","volume":"149","author":[{"given":"Huiyang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidong","family":"Fana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Zedenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weng-Onn","family":"Lui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112796_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-981-13-2835-0_9","article-title":"Telomeres, telomerase and ageing","volume":"90","author":"Saretzki","year":"2018","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.biopha.2022.112796_bib2","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","article-title":"Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players","volume":"38","author":"Yuan","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.112796_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0531-5565(96)00005-8","article-title":"Telomeres, telomerase, and aging: origin of the theory","volume":"31","author":"Olovnikov","year":"1996","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.biopha.2022.112796_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopha.2018.02.073","article-title":"Telomerase activity and telomere on stem progeny senescence","volume":"102","author":"Brazvan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112796_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1241779","article-title":"RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication","volume":"342","author":"Vannier","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112796_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2004.05.026","article-title":"Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein","volume":"117","author":"Ding","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.112796_bib7","doi-asserted-by":"crossref","first-page":"E3408","DOI":"10.1073\/pnas.1300600110","article-title":"Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome","volume":"110","author":"Deng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112796_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ajhg.2013.02.001","article-title":"Constitutional mutations in RTEL1 cause severe dyskeratosis congenita","volume":"92","author":"Walne","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2022.112796_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cell.2017.11.047","article-title":"Stabilization of reversed replication forks by telomerase drives telomere catastrophe","volume":"172","author":"Margalef","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.112796_bib10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/abbs\/gmaa126","article-title":"miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1","volume":"52","author":"Wang","year":"2020","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.biopha.2022.112796_bib11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1073\/pnas.97.3.1230","article-title":"Overexpression of M68\/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster","volume":"97","author":"Bai","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112796_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ng.408","article-title":"Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility","volume":"41","author":"Wrensch","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2022.112796_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ng.3823","article-title":"Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors","volume":"49","author":"Melin","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2022.112796_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207660","article-title":"Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population","volume":"13","author":"Namgoong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112796_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biopha.2022.112796_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2022.112796_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2022.112796_bib18","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.112796_bib19","doi-asserted-by":"crossref","unstructured":"S. Gupta, H. Won, K. Chadalavada, G.J. Nanjangud, Y.B. Chen, H.A. Al-Ahmadie, S.W. Fine, S.J. Sirintrapun, V.E. Strong, N. Raj, D.R. Lagunes, C.M. Vanderbilt, M.F. Berger, M. Ladanyi, S. Dogan, S.K. Tickoo, V.E. Reuter, A. Gopalan, TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas, Endocr Pathol, 2021.","DOI":"10.1007\/s12022-021-09691-0"},{"key":"10.1016\/j.biopha.2022.112796_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/ERC-14-0016","article-title":"The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2022.112796_bib21","first-page":"1675","article-title":"TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma","volume":"42","author":"Svahn","year":"2018","journal-title":"Int J. Mol. Med."},{"key":"10.1016\/j.biopha.2022.112796_bib22","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jcb.25811","article-title":"Telomerase and N-cadherin differential importance in adrenocortical cancers and adenomas","volume":"118","author":"Pereira","year":"2017","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.biopha.2022.112796_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.112796_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2022.112796_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.biopha.2022.112796_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.humpath.2009.03.010","article-title":"The Weiss system for evaluating adrenocortical neoplasms: 25 years later","volume":"40","author":"Lau","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.biopha.2022.112796_bib27","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1218370","article-title":"Wnt\/beta-catenin signaling regulates telomerase in stem cells and cancer cells","volume":"336","author":"Hoffmeyer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112796_bib28","doi-asserted-by":"crossref","first-page":"32494","DOI":"10.1074\/jbc.M112.368282","article-title":"Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt\/beta-catenin pathway in human cancer","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112796_bib29","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/sj.onc.1203890","article-title":"Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells","volume":"19","author":"Xu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.112796_bib30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/374565","article-title":"Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome","volume":"72","author":"Zhang","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2022.112796_bib31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.aab0015","article-title":"Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer","volume":"348","author":"Bell","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112796_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.07.003","article-title":"TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends","volume":"493","author":"Yuan","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.112796_bib33","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/1078-0432.CCR-05-0099","article-title":"Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues","volume":"11","author":"Fan","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.112796_bib34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11248-011-9586-7","article-title":"Generation of a mouse model for studying the role of upregulated RTEL1 activity in tumorigenesis","volume":"21","author":"Wu","year":"2012","journal-title":"Transgenic Res."},{"key":"10.1016\/j.biopha.2022.112796_bib35","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.1093\/nar\/gkw549","article-title":"hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor","volume":"44","author":"Liu","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2022.112796_bib36","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.2174\/1381612820666140630095606","article-title":"Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress","volume":"20","author":"Saretzki","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2022.112796_bib37","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1158\/0008-5472.CAN-16-1887","article-title":"WNT\/beta-catenin directs self-renewal symmetric cell division of hTERT(high) prostate cancer stem cells","volume":"77","author":"Zhang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.112796_bib38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1006\/cbir.2002.0961","article-title":"Telomerase-dependent reactivation of DNA synthesis in macrophages implies alteration of telomeres","volume":"26","author":"Yegorov","year":"2002","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.biopha.2022.112796_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2018.07.013","article-title":"Telomerase reverse transcriptase regulates DNMT3B expression\/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma","volume":"434","author":"Yu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.112796_bib40","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1038\/onc.2012.441","article-title":"Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells","volume":"32","author":"Liu","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.112796_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0092-8674(03)00550-6","article-title":"Telomerase maintains telomere structure in normal human cells","volume":"114","author":"Masutomi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.112796_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108700","article-title":"Human telomerase reverse transcriptase recruits the beta-catenin\/TCF-4 complex to transactivate chemokine (C-C motif) ligand 2 expression in colorectal cancer","volume":"112","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112796_bib43","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1210\/clinem\/dgab471","article-title":"Whole-genome sequencing of follicular thyroid carcinomas reveal recurrent mutations in MicroRNA processing subunit DGCR8","volume":"106","author":"Paulsson","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.112796_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.117","article-title":"Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma","volume":"7","author":"Ahmad","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.112796_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.biopha.2016.05.031","article-title":"Genetics and metabolic deregulation following cancer initiation: a world to explore","volume":"82","author":"Araldi","year":"2016","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:26:08Z","timestamp":1774250768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222001846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":45,"alternative-id":["S0753332222001846"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112796","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112796"}}